673 related articles for article (PubMed ID: 12861156)
1. Graves' disease in pregnancy: prospective evaluation of a selective invasive treatment protocol.
Nachum Z; Rakover Y; Weiner E; Shalev E
Am J Obstet Gynecol; 2003 Jul; 189(1):159-65. PubMed ID: 12861156
[TBL] [Abstract][Full Text] [Related]
2. Graves' disease in two pregnancies complicated by fetal goitrous hypothyroidism: successful in utero treatment with levothyroxine.
Bliddal S; Rasmussen ÅK; Sundberg K; Brocks V; Skovbo P; Feldt-Rasmussen U
Thyroid; 2011 Jan; 21(1):75-81. PubMed ID: 21162688
[TBL] [Abstract][Full Text] [Related]
3. Management of Graves' disease during pregnancy: the key role of fetal thyroid gland monitoring.
Luton D; Le Gac I; Vuillard E; Castanet M; Guibourdenche J; Noel M; Toubert ME; Léger J; Boissinot C; Schlageter MH; Garel C; Tébeka B; Oury JF; Czernichow P; Polak M
J Clin Endocrinol Metab; 2005 Nov; 90(11):6093-8. PubMed ID: 16118343
[TBL] [Abstract][Full Text] [Related]
4. Short-term hyperthyroidism followed by transient pituitary hypothyroidism in a very low birth weight infant born to a mother with uncontrolled Graves' disease.
Higuchi R; Kumagai T; Kobayashi M; Minami T; Koyama H; Ishii Y
Pediatrics; 2001 Apr; 107(4):E57. PubMed ID: 11335778
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for neonatal thyroid dysfunction in pregnancies complicated by Graves' disease.
Uenaka M; Tanimura K; Tairaku S; Morioka I; Ebina Y; Yamada H
Eur J Obstet Gynecol Reprod Biol; 2014 Jun; 177():89-93. PubMed ID: 24726178
[TBL] [Abstract][Full Text] [Related]
6. Recurrent fetal thyrotoxicosis in a woman with Graves' disease: case report.
Ting MK; Hsu BR; Huang YY; Lin JD; Chen TC
Changgeng Yi Xue Za Zhi; 1999 Sep; 22(3):492-7. PubMed ID: 10584424
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis and successful in utero treatment of a fetal goitrous hyperthyroidism caused by maternal Graves' disease. A case report.
Heckel S; Favre R; Schlienger JL; Soskin P
Fetal Diagn Ther; 1997; 12(1):54-8. PubMed ID: 9101225
[TBL] [Abstract][Full Text] [Related]
8. Graves' disease in pregnancy years after hypothyroidism with recurrent passive-transfer neonatal Graves' disease in offspring. Therapeutic considerations.
Volpé R; Ehrlich R; Steiner G; Row VV
Am J Med; 1984 Sep; 77(3):572-8. PubMed ID: 6548082
[TBL] [Abstract][Full Text] [Related]
9. Development of primary hypothyroidism with the appearance of blocking-type antibody to thyrotropin receptor in Graves' disease in late pregnancy.
Ueta Y; Fukui H; Murakami H; Yamanouchi Y; Yamamoto R; Murao A; Santou Y; Taniguchi S; Mitani Y; Shigemasa C
Thyroid; 1999 Feb; 9(2):179-82. PubMed ID: 10090319
[TBL] [Abstract][Full Text] [Related]
10. Antenatal diagnosis and treatment of fetal hypothyroidism. A report of two cases.
Bruner JP; Dellinger EH
Fetal Diagn Ther; 1997; 12(4):200-4. PubMed ID: 9354877
[TBL] [Abstract][Full Text] [Related]
11. Thyroid function in wholly breast-feeding infants whose mothers take high doses of propylthiouracil.
Momotani N; Yamashita R; Makino F; Noh JY; Ishikawa N; Ito K
Clin Endocrinol (Oxf); 2000 Aug; 53(2):177-81. PubMed ID: 10931098
[TBL] [Abstract][Full Text] [Related]
12. Serial in utero ultrasonographic measurements of the fetal thyroid: a new complementary tool in the management of maternal hyperthyroidism in pregnancy.
Cohen O; Pinhas-Hamiel O; Sivan E; Dolitski M; Lipitz S; Achiron R
Prenat Diagn; 2003 Sep; 23(9):740-2. PubMed ID: 12975785
[TBL] [Abstract][Full Text] [Related]
13. In utero diagnosis and treatment of fetal goitrous hypothyroidism, caused by maternal use of propylthiouracil.
Van Loon AJ; Derksen JT; Bos AF; Rouwé CW
Prenat Diagn; 1995 Jul; 15(7):599-604. PubMed ID: 8532617
[TBL] [Abstract][Full Text] [Related]
14. Persistent Graves' hyperthyroidism despite rapid negative conversion of thyroid-stimulating hormone-binding inhibitory immunoglobulin assay results: a case report.
Ohara N; Kaneko M; Kitazawa M; Uemura Y; Minagawa S; Miyakoshi M; Kaneko K; Kamoi K
J Med Case Rep; 2017 Feb; 11(1):32. PubMed ID: 28162094
[TBL] [Abstract][Full Text] [Related]
15. A case of fetal hyperthyroidism treated with maternal administration of methimazole.
Sato Y; Murata M; Sasahara J; Hayashi S; Ishii K; Mitsuda N
J Perinatol; 2014 Dec; 34(12):945-7. PubMed ID: 25421129
[TBL] [Abstract][Full Text] [Related]
16. Successful intrauterine therapy for fetal goitrous hypothyroidism during late gestation.
Miyata I; Abe-Gotyo N; Tajima A; Yoshikawa H; Teramoto S; Seo M; Kanno K; Sugiura K; Tanaka T; Eto Y
Endocr J; 2007 Dec; 54(5):813-7. PubMed ID: 17917306
[TBL] [Abstract][Full Text] [Related]
17. Congenital thyrotoxicosis in premature infants.
Smith C; Thomsett M; Choong C; Rodda C; McIntyre HD; Cotterill AM
Clin Endocrinol (Oxf); 2001 Mar; 54(3):371-6. PubMed ID: 11298090
[TBL] [Abstract][Full Text] [Related]
18. Central congenital hypothyroidism due to gestational hyperthyroidism: detection where prevention failed.
Kempers MJ; van Tijn DA; van Trotsenburg AS; de Vijlder JJ; Wiedijk BM; Vulsma T
J Clin Endocrinol Metab; 2003 Dec; 88(12):5851-7. PubMed ID: 14671180
[TBL] [Abstract][Full Text] [Related]
19. Fetal Goitrous Hyperthyroidism in a Pregnant Woman with Triiodothyronine-Predominant Graves' Disease.
Washio K; Uenaka M; Tanimura K; Deguchi M; Nishida K; Fujioka K; Yamada H
Kobe J Med Sci; 2021 Feb; 66(4):E153-E158. PubMed ID: 33994519
[TBL] [Abstract][Full Text] [Related]
20. Antithyroid drug therapy for Graves' disease during pregnancy. Optimal regimen for fetal thyroid status.
Momotani N; Noh J; Oyanagi H; Ishikawa N; Ito K
N Engl J Med; 1986 Jul; 315(1):24-8. PubMed ID: 2423874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
